Brandinium

Trademark search for:

TEPEZZA ONBE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2023-03-21 — Application filed
  • 2023-03-24 — Application filed
  • 2023-04-12 — Application filed
  • 2023-11-13 — Assigned to examiner
  • 2023-11-16 — Approved for pub - principal register
  • 2023-11-29 — Notification of notice of publication e-mailed
  • 2023-12-19 — Published for opposition
  • 2023-12-19 — Official gazette publication confirmation e-mailed
  • 2024-02-13 — Noa e-mailed - sou required from applicant
  • 2024-02-29 — Teas revoke/app/change addr of atty/dom rep received
  • 2024-02-29 — Teas change of correspondence received
  • 2024-02-29 — Attorney/dom.rep.revoked and/or appointed
  • 2024-09-16 — Application abandoned
  • 2024-09-16 — Application abandoned
  • 2024-09-16 — Final status recorded

Owner Information

Horizon Therapeutics Ireland DAC
Dublin 2 IE
Horizon Therapeutics Ireland DAC
Dublin 2 IE

Correspondent

Elsa D. Lemoine Amgen Inc.
One Amgen Center Drive
Trademark Operations MS-28-5A
Thousand Oaks, CA 91320-1799

Filing Details

Filing Date:
2023-03-21
Status Date:
2024-09-16
Category:
Pharmaceuticals
Filing Year:
2023

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.